Orientation
Rapid review
What you should already have
About 55 minutes
Plus the time it takes to redraw this lesson’s figures from memory, which is the fastest way to find out what you have not understood.
Where this shows up
The transport section is the direct physiological basis of why some drugs act centrally and others do not — atropine against glycopyrrolate, physostigmine against neostigmine. The barrier is also why arterial carbon dioxide, and not arterial pH, is the acute drive to ventilation.
Learning outcomes
By the end of this lesson you should be able to:
- Describe the three structural elements of the blood-brain barrier and name the feature of cerebral capillary endothelium that each contributes.
- State which substances cross freely, which are excluded, and predict crossing from molecular size, lipid solubility, charge and protein binding.
- Name each transport mechanism across the barrier with a correct example, and classify GLUT1-mediated glucose transport correctly.
- List the functions of the barrier beyond exclusion, including enzymatic and immunological functions.
- Name the circumventricular organs and explain why each needs an incomplete barrier.
- Explain how a rise in arterial carbon dioxide changes the brain interstitium, and why bicarbonate and hydrogen ion behave differently from carbon dioxide.
- List the conditions that disrupt the barrier and state the anaesthetic consequence of each.
Together these settle one syllabus objective: The blood–brain barrier and cerebrospinal fluid. Tick it on the Physiology objective list once you can do all of the above without notes.
The minimum high-yield framework
- Definition. A physiological barrier between the cerebral capillaries and the extracellular fluid of the brain, which provides a favourable environment for nervous tissue by being selectively permeable.
- Three structural elements. Capillary endothelium with tight junctions, no fenestrations and abundant mitochondria; a continuous basement membrane; and the closely applied astrocyte foot processes with intercellular clefts in the perivascular area.
- Pore size. About 65 Å between endothelial cells in most capillary beds; about 8 Å in the brain.
- Crosses freely: oxygen, carbon dioxide, water, lipid-soluble unionised substances of molecular weight below about 30 kDa. Excluded: large, polar or lipid-insoluble substances, and protein-bound drug.
- Five transport mechanisms: simple diffusion, facilitated diffusion (GLUT1 for glucose — not active transport), primary and secondary active transport (calcium, magnesium, chloride; efflux pumps), and pinocytosis or receptor-mediated transcytosis.
- Functions: a constant brain extracellular environment; protection from toxins and from circulating neurotransmitters and hormones; enzymatic degradation of substances at the endothelium; a barrier to microorganisms; and restriction of peripheral immune access.
- Not everywhere. The circumventricular organs lack it, on purpose.
- Carbon dioxide crosses freely; hydrogen ion and bicarbonate do not. That single asymmetry explains central chemoreception, the effect of hyperventilation on cerebral blood flow, and why CSF pH adapts over hours.
Three elements
The anatomical structure
The blood-brain barrier: three structural elements, five ways across
Structure. The barrier is not one thing but three: a capillary endothelium whose cells are joined by tight junctions (zonulae occludentes), have no fenestrations, and contain an unusually high density of mitochondria to power the transporters; a continuous basement membrane; and the closely applied foot processes of astrocytes covering most of the capillary surface. Elsewhere in the body, gaps between endothelial cells are about 65 Å across; in the brain, tight junctions reduce the effective pore to about 8 Å, which is what excludes large molecules and most ions.
Routes across, numbered on the figure. 1 Free lipid diffusion — oxygen, carbon dioxide, volatile anaesthetics, and unionised lipid-soluble drugs. 2 Aqueous diffusion through the narrowed junction — water and very small polar molecules only. 3 Carrier-mediated facilitated diffusion, down a gradient and without ATP: glucose on GLUT1, and amino acids on their own carriers. 4 Primary and secondary active transport, against a gradient and requiring ATP: sodium, potassium, calcium, magnesium and chloride, and the efflux pumps such as P-glycoprotein that push drugs back out. 5 Vesicular transport — pinocytosis and receptor-mediated transcytosis for insulin, transferrin and other large molecules; normally very limited, which is why it is the mechanism most often omitted in examination answers.
| Element | Features | Contribution |
|---|---|---|
| Capillary endothelium | Tight junctions (zonulae occludentes) between adjacent cells; no fenestrations; a high content of mitochondria | The tight junctions are the barrier proper. Elsewhere in the body, gaps between endothelial cells are about 65 Å; here they are reduced to about 8 Å. The mitochondrial density powers the carriers and pumps that replace free diffusion. |
| Basement membrane | A continuous basal lamina beneath the endothelium | Continuous, unlike the discontinuous basement membrane of a sinusoidal capillary. A second physical layer, and the scaffold the other two elements attach to. |
| Astrocyte foot processes | Perivascular end-feet covering most of the capillary surface, with intercellular clefts between them, lying beyond the basement membrane | Not themselves a diffusion barrier — the clefts between them are open — but they induce and maintain the endothelial tight junctions, and carry the aquaporin-4 channels that handle water movement. |
| Pericytes | Contractile cells embedded within the basement membrane | Contribute to barrier induction and to capillary tone. A recent addition to the classical three-element description; name the first three first. |
Predicting from first principles
What crosses, and what does not
| Property | Effect on penetration | Worked example |
|---|---|---|
| Lipid solubility | The dominant determinant. High lipid solubility means rapid diffusion through the endothelial membrane. | Thiopentone is highly lipid-soluble and produces loss of consciousness in one arm-brain circulation time. Its effect is terminated by redistribution, not metabolism. |
| Molecular size | Small molecules cross faster. Substances above about 30 kDa are effectively excluded unless carried. | Sugammadex, at about 2.2 kDa but highly polar, does not enter the brain; this is why it cannot reverse central effects. |
| Degree of ionisation | Only the unionised fraction crosses by the lipid route. Governed by pKa and pH. | Glycopyrrolate is a quaternary amine, permanently charged, and does not cross — so it has no central anticholinergic effect. Atropine is a tertiary amine, partly unionised, and does, which is why it can cause central anticholinergic syndrome. |
| Protein binding | Only free drug crosses. High binding reduces the gradient available. | The unbound fraction is what matters in hypoalbuminaemia, where the same total dose produces a larger free concentration and a greater central effect. |
Two further modifiers are worth stating. Active efflux by P-glycoprotein can make a lipid-soluble drug behave as though it were excluded — loperamide is the standard example, an opioid that is lipid-soluble but pumped straight back out and therefore has no central effect at normal doses. And the barrier is not uniform: it is absent at the circumventricular organs, and it is broken in disease.
Five routes
Every transport mechanism, with the example that fixes it
| Mechanism | How it works | Examples | Note |
|---|---|---|---|
| Simple diffusion — lipid pathway | Straight through the endothelial cell membrane, down a concentration gradient. No carrier, no energy. | Oxygen, carbon dioxide, water (also by aquaporin), volatile anaesthetics, and unionised lipid-soluble drugs — thiopentone, propofol, fentanyl, alcohol, nicotine | Rate depends on lipid solubility, molecular size, degree of ionisation and the concentration gradient. Permeable to substances of molecular weight below about 30 kDa if lipid-soluble. |
| Simple diffusion — aqueous pathway | Through the intercellular junction. Almost closed here. | Water and very small polar molecules only | This is the pathway the tight junctions abolish, which is why the barrier exists at all. Large, polar or lipid-insoluble substances are excluded. |
| Facilitated diffusion | Carrier-mediated, down a concentration gradient. Saturable, stereospecific, competitively inhibitable. No ATP. | Glucose on GLUT1; amino acids on the large neutral amino acid transporter (which is how levodopa enters); lactate and ketones on monocarboxylate transporters | GLUT1 is the example to know, and the one most often misclassified as active transport. It is carrier-mediated but needs no ATP. |
| Primary active transport | Against a gradient, hydrolysing ATP directly | Na⁺/K⁺-ATPase at the abluminal membrane; the efflux pumps, especially P-glycoprotein and the multidrug resistance proteins | P-glycoprotein actively returns lipid-soluble drugs to the blood, which is why some lipophilic agents penetrate far less than their partition coefficient predicts. |
| Secondary active transport | Against a gradient, using the sodium gradient rather than ATP directly | Calcium, magnesium and chloride handling; potassium regulation; the glutamate transporters | This is the mechanism that holds CSF and interstitial ion concentrations independent of plasma. |
| Vesicular transport | Pinocytosis and receptor-mediated transcytosis. Energy-dependent. | Insulin, transferrin, leptin and other large molecules that must reach the brain | Normally very limited — cerebral endothelium has far fewer pinocytotic vesicles than systemic endothelium. It is the mechanism most often left off the list of five. |
Previously examinedApril 2022 · April 2025 — the anatomical structure of the barrier, the mechanisms of transport across it, and its other functions. Worked answers in the library
Beyond exclusion
Functions of the barrier
- Maintaining the constancy of the brain extracellular fluid, so that neuronal function is not disturbed by changes in plasma composition. A patient’s plasma potassium can move considerably without altering neuronal excitability.
- Protection from potentially harmful substances circulating in plasma — toxins, drugs and metabolic waste.
- Preventing the uncontrolled passage of circulating neurotransmitters and hormones into the brain, and equally of centrally released ones into the systemic circulation. Without this, every rise in plasma catecholamines would be a central event.
- Enzymatic degradation at the endothelium. Endothelial cells contain monoamine oxidase and dopa decarboxylase, which metabolise substances in transit and so prevent them entering the brain extracellular fluid. This is an enzymatic barrier working alongside the physical one.
- A barrier to microorganisms entering the brain.
- Restriction of peripheral immune access — signalling molecules, antibodies and immune cells. The brain is relatively immune-privileged as a result.
- Allowing free access to metabolic substrates. The barrier is selective rather than simply exclusive: glucose, oxygen and essential amino acids have dedicated routes in.
The deliberate gaps
The circumventricular organs
| Organ | Location | Why it must sample the blood |
|---|---|---|
| Area postrema (chemoreceptor trigger zone) | Floor of the fourth ventricle | Detects circulating emetogens — the basis of chemotherapy-induced and opioid-induced vomiting, and the site at which ondansetron and droperidol act |
| Median eminence | Hypothalamus | Releases hypothalamic releasing hormones into the hypophyseal portal system |
| Subfornical organ | Roof of the third ventricle | Senses circulating angiotensin II and osmolality; drives thirst and vasopressin release |
| Organum vasculosum of the lamina terminalis (OVLT) | Anterior wall of the third ventricle | Osmoreception |
| Posterior pituitary (neurohypophysis) | Sella turcica | Secretes vasopressin and oxytocin directly into the circulation |
| Pineal gland | Posterior third ventricle | Secretes melatonin into the circulation |
| Choroid plexus | All four ventricles | Its capillary is fenestrated because ultrafiltration is the first step in CSF production; the barrier here is the epithelium instead |
Naming even three or four of these, with the reason each needs an incomplete barrier, turns a memorised list into an explanation. The area postrema is the one to name first, because it is the one with daily anaesthetic consequences.
The asymmetry that matters most
Carbon dioxide, hydrogen ion and the brain interstitium
Carbon dioxide is small, uncharged and lipid-soluble, so it crosses the blood-brain barrier freely and almost instantaneously. Hydrogen ion and bicarbonate are charged, and cross only slowly, by regulated transport. That asymmetry has four consequences, and they are worth stating as a chain:
- A rise in arterial carbon dioxide is transmitted directly to the brain interstitium and to CSF within seconds.
- It is hydrated to carbonic acid, a reaction catalysed by carbonic anhydrase, which dissociates to hydrogen ion and bicarbonate. Interstitial and CSF pH therefore fall.
- The fall is large, because CSF has a very low protein concentration — about 0.2-0.4 g/L against 70 g/L in plasma — and therefore very little non-bicarbonate buffering. The same change in carbon dioxide moves CSF pH further than it moves plasma pH — the buffering point is as important as the diffusion one.
- The central chemoreceptors on the ventral medulla read that pH change and drive ventilation. This is why arterial carbon dioxide, not arterial pH, is the dominant acute stimulus to breathing, and why an acute metabolic acidosis takes far longer to stimulate ventilation than an equivalent respiratory one.
The same asymmetry sets the time course of hyperventilation. Hypocapnia produces immediate interstitial alkalosis and cerebral vasoconstriction, but bicarbonate is then transported out of the CSF over the following six to eight hours, CSF pH returns toward normal, and the vasoconstriction is lost. Two clinical rules follow. Hyperventilation is a short-term rescue, not a treatment. And abruptly restoring a normal arterial carbon dioxide after a sustained period of hypocapnia produces a CSF acidosis, cerebral vasodilatation and a rise in intracranial pressure — so carbon dioxide should be normalised gradually.
When the barrier fails
Barrier breakdown, and what it produces
| Cause | Mechanism | Consequence |
|---|---|---|
| Acute hypertension above the upper limit of autoregulation | Forced dilatation of arterioles, raised capillary hydrostatic pressure and mechanical disruption of tight junctions | Hypertensive encephalopathy; vasogenic oedema; the mechanism behind posterior reversible encephalopathy syndrome |
| Trauma and surgery | Direct mechanical disruption | Vasogenic oedema around a contusion; the reason mannitol is less effective where the barrier is already open |
| Ischaemia and reperfusion | Energy failure of the endothelium, then free-radical and protease damage | Oedema that worsens after flow is restored |
| Infection and inflammation | Cytokines open tight junctions; leucocytes migrate across | Meningitis; also the reason some antibiotics penetrate an inflamed meninx better than a healthy one |
| Tumour | Neovessels formed by tumour angiogenesis have no tight junctions and are fenestrated | The basis of contrast enhancement on imaging, and of peritumoral vasogenic oedema |
| Marked hyperosmolality | Endothelial cell shrinkage pulls tight junctions apart | Used deliberately to deliver chemotherapy; a caution when giving repeated osmotherapy |
| Seizures and severe hypercapnia | Marked hyperaemia raises capillary pressure | Transient opening |
| Volatile anaesthetic agents | Isoflurane at 1% causes albumin extravasation into the thalamus in animals; at 3% the effect extends to cortex, quantitatively similar to that produced by mannitol | Experimental; the clinical relevance is not established, and should be presented as such |
| Vasogenic | Cytotoxic | |
|---|---|---|
| Barrier | Broken | Intact |
| Fluid accumulates | In the extracellular space | Inside cells, especially astrocytes |
| Mechanism | Protein-rich plasma filtrate leaks across a disrupted barrier, and water follows the oncotic gradient | Energy failure stops the Na⁺/K⁺-ATPase; sodium and water enter cells |
| Typical causes | Tumour, abscess, trauma, hypertensive encephalopathy, late ischaemia | Early ischaemia, hypoxia, acute hyponatraemia |
| Response to osmotherapy | Limited — the barrier will not hold the osmotic gradient | Good, because the barrier is intact and can sustain the gradient |
| Response to corticosteroids | Good, particularly around tumours | None |
This distinction is the reason dexamethasone works around a cerebral tumour and does nothing after a stroke or a head injury, and the reason mannitol is less effective where the barrier is already open — the osmotic gradient it creates cannot be sustained across a leaking barrier, and the mannitol itself may cross and reverse the gradient with repeated dosing.
Anaesthetic and clinical application
What the barrier decides in daily practice
| Drug | Crosses? | Why | Clinical consequence |
|---|---|---|---|
| Thiopentone, propofol | Yes, rapidly | Small, highly lipid-soluble, largely unionised at pH 7.4 | Onset within one arm-brain circulation time; offset by redistribution |
| Non-depolarising neuromuscular blockers | No | Large and permanently charged quaternary compounds | No sedation, no amnesia — the reason awareness under paralysis is possible |
| Neostigmine | No | Quaternary ammonium | Reverses peripheral blockade without central cholinergic effects |
| Physostigmine | Yes | Tertiary amine | The treatment for central anticholinergic syndrome |
| Glycopyrrolate | No | Quaternary ammonium | Antisialagogue and vagolytic without confusion |
| Atropine | Yes | Tertiary amine | Can cause central anticholinergic syndrome, especially in the elderly |
| Morphine | Slowly | Relatively polar for an opioid | Delayed peak effect; the reason intrathecal morphine spreads rostrally in CSF and can cause late respiratory depression |
| Fentanyl | Rapidly | Highly lipid-soluble | Fast onset; intrathecally it is taken up locally rather than spreading far |
| Loperamide | Effectively no | Lipid-soluble but a P-glycoprotein substrate, actively pumped out | An opioid with no central effect at therapeutic dose |
| Dopamine | No | Polar catecholamine | An intravenous infusion has no direct central effect; levodopa is used instead when a central effect is wanted |
| Levodopa | Yes | Carried on the large neutral amino acid transporter | Given with a peripheral decarboxylase inhibitor that cannot cross |
Two general rules fall out of that table and are worth stating in any answer. A quaternary ammonium compound does not enter the brain. And the barrier is a reason a drug may be less effective centrally than its lipid solubility predicts, because of active efflux.
Consolidation
The lesson in one paragraph
The blood-brain barrier is a physiological barrier between the cerebral capillaries and the brain extracellular fluid, selectively permeable so as to provide a favourable environment for neuronal function. It is formed by capillary endothelium whose cells are joined by tight junctions, lack fenestrations and contain abundant mitochondria; by a continuous basement membrane; and by the closely applied astrocyte foot processes with intercellular clefts in the perivascular area. Tight junctions reduce the intercellular pore from about 65 Å elsewhere to about 8 Å here. Oxygen, carbon dioxide, water and lipid-soluble unionised substances below about 30 kDa cross freely; large, polar and lipid-insoluble substances do not. Transport occurs by simple diffusion, facilitated diffusion (glucose on the insulin-independent GLUT1 carrier, which requires no ATP), primary and secondary active transport (calcium, magnesium and chloride, and efflux pumps such as P-glycoprotein), and vesicular transport by pinocytosis and receptor-mediated transcytosis. Its functions are to keep the brain extracellular environment constant, to protect against toxins, to prevent uncontrolled passage of circulating neurotransmitters and hormones, to degrade substances enzymatically at the endothelium through monoamine oxidase and dopa decarboxylase, to exclude microorganisms and to restrict peripheral immune access. The circumventricular organs — area postrema, median eminence, subfornical organ, OVLT, posterior pituitary, pineal and choroid plexus — lack the barrier because they must sample or secrete into blood. Carbon dioxide crosses freely while hydrogen ion and bicarbonate do not, so arterial carbon dioxide sets CSF pH within seconds and, because CSF is poorly buffered, does so steeply — the basis of central chemoreception and of the six-to-eight-hour loss of effect of sustained hyperventilation. The barrier is disrupted by trauma, tumour, infection, ischaemia, severe hypertension and marked hyperosmolality, producing vasogenic oedema, which responds to corticosteroids but not well to osmotherapy.